| 21 |
|
Differential response of human acute myeloid leukemia cells to gemtuzumab ozogamicin in vitro: role of Chk1 and Chk2 phosphorylation and caspase 3/
|
Amico, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 22 |
|
Differential STAT3, STAT5, and NF-kappaB activation in human hematopoietic progenitors by endogenous interleukin-15: implications in the expression of functional molecules/
|
Giron-Michel, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 23 |
|
Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor/
|
Stebbing, J
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 24 |
|
Disentangling iron regulatory networks/
|
Weiss, G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 25 |
|
Disruption of the beta~3 663-687 disulfide bridge confers constitutive activity to beta~3 integrins/
|
Butta, N
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 26 |
|
Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation/
|
Plett, P. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 27 |
|
Distribution of plasma membrane Ca^2^+ pump activity in normal human red blood cells/
|
Lew, V. L
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 28 |
|
Divergence from the germ-line sequence in unmutated chronic lymphocytic leukemia is due to somatic mutation rather than polymorphisms/
|
Davis, Z. A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 29 |
|
Docosahexaenoic acid enhances arsenic trioxide-mediated apoptosis in arsenic trioxide-resistant HL-60 cells/
|
Sturlan, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 30 |
|
Do human myeloma cells directly produce basic FGF?/
|
Colla, S
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 31 |
|
Donor serostatus and CMV infection and disease among recipients of prophylactic granulocyte transfusions/
|
Nichols, W. G
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 32 |
|
Don't GO to VOD/
|
Bearman, S. I
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 33 |
|
Do V~L genes have prognostic relevance?/
|
Solomon, A
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 34 |
|
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias/
|
Cilloni, D
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 35 |
|
Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells/
|
Deutsch, E
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 36 |
|
Down syndrome and megakaryocytic leukemia/transient myeloproliferative disorder: when does it begin?/
|
Taub, J. W
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 37 |
|
Drug-induced thrombocytopenia: localization of the binding site of GPIX-specific quinine-dependent antibodies/
|
Asvadi, P
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 38 |
|
Dual effects of macrophage inflammatory protein-1alpha on osteolysis and tumor burden in the murine 5TGM1 model of myeloma bone disease/
|
Oyajobi, B. O
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 39 |
|
Dynamic tracking of human hematopoietic stem cell engraftment using in vivo bioluminescence imaging/
|
Wang, X
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|
| 40 |
|
Dysfunction and infection of freshly isolated blood myeloid and plasmacytoid dendritic cells in patients infected with HIV-1/
|
Donaghy, H
|
W.B. Saunders Co., etc.]
|
2003
|
|
|
|